| |
Overall
|
|---|
| |
N = 190
|
%
|
|---|
|
Age at diagnosis
| |
|---|
|
>50
|
170
|
89.5%
|
|
≤50
|
20
|
10.5%
|
|
Median
|
68
| |
|
Range
|
30-89
| |
|
Nodal status
| | |
|
Positive
|
68
|
35.8%
|
|
Negative
|
122
|
64.2%
|
|
Stage
| | |
|
I
|
47
|
24.7%
|
|
II
|
119
|
62.6%
|
|
III
|
24
|
12.6%
|
|
Histology
| | |
|
Ductal
|
171
|
90.0%
|
|
Other
|
19
|
10.0%
|
|
T stage
| | |
|
T1
|
64
|
33.7%
|
|
T2-T4
|
122
|
64.2%
|
|
Grade
a
| | |
|
I
|
49
|
43.0%
|
|
II
|
58
|
50.9%
|
|
III
|
7
|
6.1%
|
|
ER
| | |
|
Positive
|
186
|
97.9%
|
|
Negativeb
|
4
|
2.1%
|
|
PR
| | |
|
Positive
|
140
|
73.7%
|
|
Negative
|
50
|
34.2%
|
- aDistribution of grade among patients where grade was available; bfour patients were estrogen receptor (ER)-negative but progesterone receptor (PR)-positive, thus hormone receptor-positive.
